About this episode
Paul is the Co-Founder & CEO of Molecule as well as the Co-Initiator of VitaDAO. He has spent several years working in the blockchain space from organizing Ethereum meetups in South Africa to serving as Director of Business Development for ConsenSys. Paul is working on building a marketplace for drug discovery and development through the use of blockchain technology, enabling IP NFTs and bootstrapping DAOs to invest in them. Follow Paul on Twitter @paulkhls.
[2:18] - How online forums led Paul to drug development and cryptocurrencies
[14:34] - Paul's perspective on the US patent model and how it can be improved to foster innovation
[24:05] - Molecule's use of NFTs for intellectual property ("IP NFTs") in the biotech and pharmaceutical industries
[34:29] - Rethinking fundraising in the biotech and pharmaceutical industries
[41:10] - Democratizing access to longevity technologies
[44:12] - The future of decentralized drug development
---
Support the show by checking out my sponsors:
Join Levels and get personalized insights to learn about your metabolic health. Go to https://levels.link/jake.
---
Get every episode summarized
Each time POD OF JAKE publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
